AzTrials
AzTrials

AnesthesiaSPIDERNCT03218306

Surgical Pleth Index (SPI) Versus Standard Clinical Approach Analgesia

A study testing Surgical Pleth Index and Clinical guidance in people with Anesthesia and Pain, run by University of Cagliari at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study is aimed at confronting a surgical pleth index based protocol for intraoperative analgesia in a desflurane based general anesthesia for thyroidectomy, versus a standard clinical approach. A reduction in analgesic consumption and improvement in hemodynamics are expected. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Anesthesia, Pain, Surgery
What is being tested?
Surgical Pleth Index and Clinical guidance
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
198 participants
Where
1 siteItaly
Study dates
23 Oct 2017to 1 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18<age<80 years
  • American society of anesthesiology (ASA) physical status I -II
  • 6 hrs fasting

Who cannot join

  • Arrhythmia or Pacemaker
  • Central or peripheral nervous system or muscular disease
  • Drugs active on autonomous nervous system (eg clonidine)
  • Obesity (BMI >35)
  • Chronic Pain
  • Addictions or central nervous acting drugs use
Show all 12Show fewer
  • Hypertension (if not treated)
  • Connective tissue disease
  • Pregnancy
  • Allergy or hypersensitivity to study drugs
  • QT prolongation
  • Absence of inclusion criteria

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Policlinico Duilio Casula

    Monserrato, Cagliari, 09072

    Paolo Mura, MD, +39 3476527512, mura_paolo@hotmail.com

    Paolo Onida, MD

    Recruiting

Other trials in Italy

About this study

Official title: Surgical Pleth Index Guided Intraoperative Analgesia Versus Standard Clinical Approach During Desflurane Based General Anesthesia for Thyroidectomy

The study is aimed at confronting a surgical pleth index based protocol for intraoperative analgesia in a desflurane based general anesthesia for thyroidectomy, versus a standard clinical approach. A reduction in analgesic consumption and improvement in hemodynamics are expected.

Conditions
Anesthesia, Pain, Surgery
Being tested
Surgical Pleth Index, Clinical guidance
Keywords
SPI, Remifentanil, Target controlled infusion
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Surgical Pleth IndexDevice

    Effector site concentration of remifentanil based on SPI

  • Clinical guidanceOther

    Effector site concentration of remifentanil based on hemodynamic data

Study groups in NCT03218306
Study groupRoleWhat they receive
SPI guided analgesiaExperimentalSPI ≤ 10 percentual points over the post-induction/pre-surgical incision value
Receives: Device: Surgical Pleth Index
Clinical Guided AnalgesiaActive comparatorNo SPI guidance
Receives: Other: Clinical guidance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Remifentanil consumption

    Cumulative remifentanil consumption throughout surgery

    Measured: Intraoperative

Secondary outcomes (7)
  1. Hemodynamics

    Cumulative number of episodes of hypotension or hypertension or brady/tachycardia

    Measured: intraoperative

  2. Desflurane

    Cumulative consumption of desflurane (ml) as measured by datex ohmeda aysis ventilator

    Measured: intraoperative

  3. Extubation delay

    Timespan between end of surgery and extubation

    Measured: intraoperative

  4. Post-operative analgesia 1

    Evaluate the total consumption of analgesics in the first 24 hours after surgery

    Measured: 24 hr post operative

  5. Post-operative analgesia 2

    measure pain in the first post-operative day

    Measured: 24 hr post operative

  6. Adverse reactions

    Nausea and vomiting in the 1st post-operative day

    Measured: 24 hr post operative

  7. Patient satisfaction

    Evaluate on a 0-4 numeric scale patient satisfaction

    Measured: 24 hr post operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2017
  2. Study start23 Oct 2017
  3. Primary completion1 Oct 2018 (estimated)
  4. Study completion1 Dec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
198 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03218306
Sponsor's protocol ID
SPI_3417
Acronym
SPIDER
Status last verified
Oct 2017
First submitted
9 Jul 2017
Last updated
26 Oct 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Surgical Pleth Index and Clinical guidance in people with Anesthesia and Pain, run by University of Cagliari at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paolo Onida, MD (+3907051096543, paolo.onida80@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Remifentanil consumption (time frame: Intraoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in